Does CARFILZOMIB Cause Hyperglycaemia? 87 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 87 reports of Hyperglycaemia have been filed in association with CARFILZOMIB (KYPROLIS). This represents 0.4% of all adverse event reports for CARFILZOMIB.
87
Reports of Hyperglycaemia with CARFILZOMIB
0.4%
of all CARFILZOMIB reports
25
Deaths
30
Hospitalizations
How Dangerous Is Hyperglycaemia From CARFILZOMIB?
Of the 87 reports, 25 (28.7%) resulted in death, 30 (34.5%) required hospitalization, and 14 (16.1%) were considered life-threatening.
Is Hyperglycaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CARFILZOMIB. However, 87 reports have been filed with the FAERS database.
What Other Side Effects Does CARFILZOMIB Cause?
Plasma cell myeloma (2,238)
Off label use (2,120)
Death (1,442)
Thrombocytopenia (1,265)
Fatigue (1,048)
Pneumonia (1,016)
Pyrexia (969)
Anaemia (910)
Dyspnoea (881)
Neutropenia (874)
What Other Drugs Cause Hyperglycaemia?
INSULIN GLARGINE (1,903)
METFORMIN (1,626)
ALPELISIB (1,575)
DEXAMETHASONE (1,169)
PREDNISONE (1,135)
INSULIN LISPRO (743)
PREDNISOLONE (705)
INSULIN ASPART (646)
INSULIN HUMAN (620)
METHYLPREDNISOLONE (604)
Which CARFILZOMIB Alternatives Have Lower Hyperglycaemia Risk?
CARFILZOMIB vs CARGLUMIC ACID
CARFILZOMIB vs CARIPRAZINE
CARFILZOMIB vs CARISOPRODOL
CARFILZOMIB vs CARMUSTINE
CARFILZOMIB vs CARTEOLOL